Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients: A systematic review of the literature with meta-analysis

Author： Berghmans T.   Paesmans M.   Lafitte J.   Mascaux C.   Meert A.   Jacquy C.   Burniat A.   Steels E.   Vallot F.   Sculier J.  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.10, Iss.3, 2002-04, pp. : 181-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutro-penic cancer patients

By Ibrahim Ezzeldin   Al-Mulhim Fatma  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 47-51

Humana Press, Inc

Access to resources Recommend Favorite

Phase trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 865-868

Science Publishers

Access to resources Recommend Favorite

Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF)

By Oshika Y.   Nakamura M.   Abe Y.   Fukuchi Y.   Yoshimura M.   Itoh M.   Ohnishi Y.   Tokunaga T.   Fukushima Y.   Hatanaka H.   Kijima H.   Yamazaki H.   Tamaoki N.   Ueyama Y.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1958-1961

Elsevier

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-stimulating Factor Therapy in Patients With Chemotherapy-induced Aplasia and Clostridium difficile Enterocolitis

By Geiger R.   Fussenegger J.   Allerberger F.   Maurer K.   Fink F.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2416-2417

Elsevier

Access to resources Recommend Favorite

Granulocyte-macrophage Colony-stimulating Factor Improves Immunological Parameters in Patients with Refractory Solid Tumours Receiving Second-line Chemotherapy: Correlation with Clinical Responses

By Baxevanis C.N.   Tsavaris N.B.   Papadhimitriou S.I.   Zarkadis I.K.   Papadopoulos N.G.   Bastounis E.A.   Papamichail M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1202-1208

Elsevier

Access to resources Recommend Favorite